This editorial aims to put the results of the study in context with the existing evidence based and understand what the results mean in terms of current practice. The authors of this study conclude that no change is required. In addition the Rapid Responses are heavily critical of the decision to stop the study early and make for interesting reading.
Action: The hype generated by the publication of this study continues. Clinicians should be aware of the study and the growing opinion that the results should not change current practice.
|« MeReC Extra 36||More glitazone data »|